Non-exclusive rebate agreement for medicines containing colistin

Summary

The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing the active substance colistin for the period 1 August 2026 to 31 July 2028, with an option to extend once by 12 months. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible for the medicines named by the bidder in Annex 2 to the contract. The exact participation and contract performance requirements must be checked in the tender documents.